Go to content
UR Home

Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study

Deutsch, Eric ; Kirzinger, Lukas ; Boy, Sandra ; Marienhagen, Jörg ; Schuierer, Gerhard ; Neu, Reiner ; Ried, Michael ; Hofmann, Hans-Stefan ; Wiebe, Karsten ; Ströbel, Philipp ; May, Christoph ; Kleylein-Sohn, Julia ; Baierlein, Claudia ; Bogdahn, Ulrich ; Marx, Alexander ; Schalke, Berthold


Therapeutic options to cure advanced, recurrent, and unresectable thymomas are limited. The most important factor for long-term survival of thymoma patients is complete resection (R0) of the tumor. We therefore evaluated the response to and the induction of resectability of primarily or locally recurrent unresectable thymomas and thymic carcinomas by octreotide Long-Acting Release (LAR) plus ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons